Safety of Oral Resin for Treatment of Hyperkalemia in Chinese Patients With Renal Insufficiency

CompletedOBSERVATIONAL
Enrollment

887

Participants

Timeline

Start Date

August 22, 2022

Primary Completion Date

December 29, 2023

Study Completion Date

December 29, 2023

Conditions
Hyperkalaemia
Trial Locations (16)

Unknown

Peking University People's Hospital, Beijing

Research Site, Beijing

Research Site, Dalian

Research Site, Dongyang

Research Site, Hangzhou

Research Site, Hefei

Research Site, Jinan

Research Site, Kaifeng

Research Site, Ningbo

Research Site, Qingdao

Research Site, Shijiazhuang

Research Site, Tianjin

Research Site, Xuzhou

Research Site, Yangzhou

Research Site, Zhangjiagang

Research Site, Zhengzhou

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY